JNE Partners LLP - Q1 2020 holdings

$96.2 Million is the total value of JNE Partners LLP's 5 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 40.0% .

 Value Shares↓ Weighting
COTY BuyCOTY INC$27,476,000
-45.7%
5,324,775
+18.4%
28.56%
-12.5%
UHAL NewAMERCO$23,418,00080,600
+100.0%
24.34%
FOX  FOX CORP$22,576,000
-37.1%
986,6970.0%23.47%
+1.3%
NG SellNOVAGOLD RES INC$22,363,000
-41.1%
3,030,229
-28.4%
23.25%
-5.0%
BUD  ANHEUSER BUSCH INBEV SA/NVsponsored adr$362,000
-46.2%
8,2000.0%0.38%
-13.4%
WBA ExitWALGREENS BOOTS ALLIANCE INC$0-506,800
-100.0%
-19.28%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-04-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RES INC16Q3 202334.9%
AMERCO11Q3 202240.0%
ELLIOTT OPPORTUNITY II CORP9Q2 202319.8%
COMCAST CORP NEW8Q1 202223.5%
ORION BIOTECH OPPORTUNTES CO8Q1 202311.1%
MSD ACQUISITION CORP8Q4 202211.1%
LIBERTY MEDIA CORP DEL8Q2 202313.9%
ROCKET INTERNET GRWT OPRT CO8Q4 20223.2%
KKR ACQUISITION HOLDING I CO7Q3 20221.7%
MICRON TECHNOLOGY INC5Q3 202356.9%

View JNE Partners LLP's complete holdings history.

Latest significant ownerships (13-D/G)
JNE Partners LLP Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Prevail Therapeutics Inc.January 29, 2021? ?

View JNE Partners LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-15

View JNE Partners LLP's complete filings history.

Compare quarters

Export JNE Partners LLP's holdings